Styrenes
![eMolecules Ambeed / transtrans-4-(4-Ethoxy-23-difluorophenyl)-4-ethyl-11-bi(cyclohexane) / 5g / 666598308 / A302043 / / 253199-08-5 / [null] / 350.494 / C22H32F2O](https://assets.fishersci.com/TFS-Assets/CCG/product-images/502424818.PNG-250.jpg)
eMolecules Ambeed / transtrans-4-(4-Ethoxy-23-difluorophenyl)-4-ethyl-11-bi(cyclohexane) / 5g / 666598308 / A302043 / / 253199-08-5 / [null] / 350.494 / C22H32F2O
Ambeed / transtrans-4-(4-Ethoxy-23-difluorophenyl)-4-ethyl-11-bi(cyclohexane) / 5g / 666598308 / A302043 / / 253199-08-5 / [null] / 350.494 / C22H32F2O
Chemscene ChemScene | β-Bromostyrene | 500G | CS-0059292 | 0.97 | 103-64-0| MFCD00000185 | 183.048
ChemScene | β-Bromostyrene | 500G | CS-0059292 | 0.97 | 103-64-0| MFCD00000185 | 183.048
Medchemexpress LLC Styrene-divinylbenzene sulfonated copolymer | 69011-20-7 | 98% | 10 G
Styrene-divinylbenzene sulfonated copolymer is a strongly acidic resin, functioning as a cationic exchange resin. It is produced from a microporous styrene/divinylbenzene (DVB) co-polymer and features a sulfonic acid group.
- Strongly acidic resin
- Cationic exchange capabilities
- Manufactured from microporous co-polymer
- Contains sulfonic acid group
eMolecules Medchem Express / Cinnamyl-34-dihydroxy--cyanocinnamate / 5mg / 596608155 / HY-138688 / / 132465-11-3 / MFCD00210839 / 321.332 / C19H15NO4
Medchem Express / Cinnamyl-34-dihydroxy--cyanocinnamate / 5mg / 596608155 / HY-138688 / / 132465-11-3 / MFCD00210839 / 321.332 / C19H15NO4
Chemscene ChemScene | (E)-1-Bromo-4-(2-nitrovinyl)benzene | 10G | CS-W016767 | 0.98 | 5153-71-9| MFCD00191856 | 228.04
ChemScene | (E)-1-Bromo-4-(2-nitrovinyl)benzene | 10G | CS-W016767 | 0.98 | 5153-71-9| MFCD00191856 | 228.04
Selleck Chemical LLC CPI-637
CPI-637 is a selective and cell-active benzodiazepinone CBP/EP300 bromodomain inhibitor with IC50 values of 0 03 M and 0 051 M for CBP and EP300 respectively in TR-FRET assay It is highly selective against other bromodomains displaying substantial biochemical activity only against BRD9
Medchemexpress LLC Omega-3 arachidonic acid ethyl ester | 123940-93-2 | 98.0% | 332.52 | C22H36O2 | 1MG
Omega-3 arachidonic acid ethyl ester is the ethyl-ester derivative of an omega-3 polyunsaturated fatty acid supplied in ethanol at high purity. It provides increased lipophilicity compared with the free acid and is intended for lipid research, formulation, and analytical applications. Molecular formula C22H36O2; molecular weight 332.52 g/mol. Available in small vial sizes suitable for analytical and preparative use.
- Supplied in ethanol at 98.0% purity.
- Ethyl ester increases lipophilicity for formulation and metabolism studies.
- Suitable for analytical and preparative lipid research.
- Molecular formula C22H36O2; molecular weight 332.52 g/mol.
- Available in small vial sizes for laboratory use.
Matrix Scientific TRIS(DIBENZYLIDENEACETONE)DI-1
Tris(dibenzylideneacetone)dipalladium-chloroform Adduct Mf C52h43cl3o3pd2 Mw 1035.08 Cas 52522-40-4 Mdl MFCD00075479
Apexbio Technology LLC NMS-873 1418013-75-8 10mM (in 1mL DMSO)
NMS-873 (CAS 1418013-75-8) is a selective inhibitor of the ATPase VCP/p97 demonstrating inhibitory activity with an IC50 value of 30 nM It targets wild-type VCP as well as VCPC522T mutants without disrupting VCP oligomerization NMS-873 exhibits selectivity against other AAA ATPases HSP90 and various kinases In tumor cell lines including HCT-116 treatment with NMS-873 induces accumulation of polyubiquitinated proteins and stabilization of cyclin E and Mcl-1 leading to altered cell-cycle distribution and reduced cell proliferation NMS-873 shows cytotoxicity across blood cancer and solid tumor cell models (IC50 values 0 08 2 M) supporting its utility in oncology research
![Medchemexpress LLC 1,3,4,5-tetrahydro-4-methyl-6-[1-methyl-3-(1-methyl-pyrazol-4-yl)-indazol-5-yl]-benzodiazepin-2-one | 1884712-47-3 | 100.0% | 386.45 g/mol | C22H22N6O | 1 ML](https://assets.fishersci.com/TFS-Assets/CCG/product-images/5000215451.png-250.jpg)
Medchemexpress LLC 1,3,4,5-tetrahydro-4-methyl-6-[1-methyl-3-(1-methyl-pyrazol-4-yl)-indazol-5-yl]-benzodiazepin-2-one | 1884712-47-3 | 100.0% | 386.45 g/mol | C22H22N6O | 1 ML
CPI-637 is a selective, cell-active benzodiazepinone inhibitor of CBP and EP300 bromodomains with potent biochemical activity and demonstrated cellular effects. It inhibits CBP and EP300 with low-nanomolar IC50 values, shows reduced activity against BRD4 BD-1, and is supplied as a concentrated solution for research use.
- Selective CBP and EP300 bromodomain inhibition.
- Potent biochemical activity (low-nanomolar IC50 values).
- Cell-active with measurable EC50 in cellular assays.
- Supplied as a concentrated solution for convenient dosing in assays.
- Suitable for epigenetics and cancer biology research applications.
- Reported high chemical purity for reproducible results.
Cambridge Isotope Laboratories omega-Muricholic acid (unlabeled) 1 mg
omega-Muricholic acid (unlabeled) 1 mg
Cambridge Isotope Laboratories 4-Methoxy-2 2 3 4-tetraBDE (unlabeled) 50 ug/mL in nonane 1 2 mL
4-Methoxy-2 2 3 4-tetraBDE (unlabeled) 50 ug/mL in nonane 1 2 mL
Medchemexpress LLC Benzamide, 2-[[5-bromo-2-[[1-(methylsulfonyl)-4-piperidinyl)amino]-4-pyrimidinyl]amino]-6-fluoro- | 2488892-01-7 | C17H20BrFN6O3S | 25 MG
TMX-2039 is a pan-CDK inhibitor for both cell cycle CDKs (CDK1, CDK2, CDK4, CDK5, and CDK6) and transcriptional CDKs (CDK7 and CDK9). It acts as a ligand for target proteins for PROTACs, demonstrating IC50 values against CDK1 (2.6 nM), CDK2 (1.0 nM), CDK4 (52.1 nM), CDK5 (0.5 nM), CDK6 (35.0 nM), CDK7 (32.5 nM), and CDK9 (25 nM).
- Pan-CDK inhibitor
- Inhibits cell cycle CDKs
- Inhibits transcriptional CDKs
- Ligand for target protein for PROTACs